Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1.
Francolini G, Thomsen MS, Yates ES, Kirkove C, Jensen I, Blix ES, Kamby C, Nielsen MH, Krause M, Berg M, Mjaaland I, Schreiber A, Kasti UM, Boye K, Offersen BV.
Francolini G, et al. Among authors: jensen i.
Radiother Oncol. 2017 May;123(2):282-287. doi: 10.1016/j.radonc.2017.03.011. Epub 2017 Mar 25.
Radiother Oncol. 2017.
PMID: 28351523
Clinical Trial.